With Zepbound Not Matching Expectations, Should Investors Give Up on Eli Lilly?
Eli Lilly (NYSE: LLY) has underperformed broader equities. While that's not much of an issue in the grand scheme of things, ...
Mounjaro menu plan: What foods to eat and avoid for optimal results
An ideal Mounjaro diet plan should focus on nutrient-dense foods, such as fruits, vegetables, whole grains, lean proteins, ...
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
Wall Street is bullish on Viking, but the company still has a lot to prove. Viking has a number of different clinical studies ...
The high cost of weight loss: How patients are fighting for access to breakthrough medications
CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
How Weight-Loss Drugs Can Upend a Marriage
Lisa Miller interviewed more than two dozen people about the effects weight-loss drugs have had on their romantic ...
'Weight-loss jabs reversed my liver cirrhosis - my doctor said it couldn't happen'
Grandmother of five Michelle Hayward was shocked when she was told she had irreversible liver damage from years of overeating ...
Why Eli Lilly and Company (LLY) Is Among the Best Long Term Low Risk Stocks to Buy Now
We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take ...
Ozempic-Like Drugs May Hold Risks For Surgical Patients, Officials Say
Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...
3 Unstoppable Stocks You Can Buy and Hold for the Rest of Your Life
If you want stocks that you can buy and hold for not only years, but potentially the rest of your life, it's important to ...
Is Eli Lilly and Company (LLY) the Most Promising Dividend Stock According to Hedge Funds?
We recently compiled a list of the 10 Most Promising Dividend Stocks According to Hedge Funds. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against ...